Clinical Trial Update: Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer [Phase 2]

View source ↗

Summary

This document reports the completed Phase II study of oxaliplatin in combination with Taxotere (docetaxel) for metastatic bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: Stanford University | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED